Review
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2011; 17(26): 3092-3100
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3092
Figure 2
Figure 2 Hypothetical relationship between inflammatory bowel disease and colitis associated colorectal cancer. The T helper (Th)2 immune response characterizing ulcerative colitis determines an elevated risk of developing colitis associated colorectal cancer (CAC). In Crohn's disease, while a Th17-mediated immune response could cause inflammation and enhance CAC risk, the shift towards a Th1-mediated colitis could lower the incidence of CAC.